100 Active Studies

Retinitis Pigmentosa Clinical Trials

Find actively recruiting research studies for retinitis pigmentosa. Connect with study sites near you and explore new treatment options.

100
Active Trials
282+
Locations
375,660
Participants Needed

Recruiting Studies

RecruitingNCT00785525

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

The purpose of the study is to: * Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors * Assess t...

4 locations(Boca Raton, Rockville, Minneapolis)
60,000 participants
Center for International Blood and Marrow Transplant Research
View Study Details
RecruitingNCT02735707

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to impro...

10 locations(Jacksonville, Augusta, Chicago)
20,000 participants
UMC Utrecht
View Study Details
RecruitingNCT06802224

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

Low blood pressure, also known as hypotension, is very common during major surgery under general anesthesia. Prolonged or severe hypotension can lead to complications such as kidney injury after surge...

2 locations(San Francisco, Ann Arbor)
18,000 participants
University of California, San Francisco
View Study Details
RecruitingNCT06292013

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart ...

10 locations(Birmingham, Daphne, Dothan)
16,700 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05754957

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major adverse cardiovascular event (MACE) (the composite of car...

10 locations(Alexander City, Birmingham, Birmingham)
16,000 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT07000357

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in ...

10 locations(Birmingham, Fairhope, Foley)
15,100 participants
AstraZeneca
View Study Details
RecruitingNCT05702034

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke....

10 locations(Mesa, Tucson, Fayetteville)
15,000 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT07064473

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...

10 locations(Anniston, Fairhope, Guntersville)
11,800 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT07157774

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart a...

10 locations(Concord, Fountain Valley, Redding)
10,450 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06534892

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 conse...

10 locations(Birmingham, Birmingham, Huntsville)
10,353 participants
GlaxoSmithKline
View Study Details
RecruitingNCT06742281

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently a...

10 locations(Anniston, Phoenix, Chula Vista)
10,016 participants
CyanVac LLC
View Study Details
RecruitingNCT05986292

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific append...

10 locations(Birmingham, Birmingham, Glendale)
10,000 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06383390

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will e...

10 locations(Alabaster, Birmingham, Daphne)
10,000 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05514054

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and huma...

10 locations(Daphne, Huntsville, Mobile)
8,000 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06424288

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more...

10 locations(Mobile, Mobile, Chula Vista)
6,000 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT07160244

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcus (GBS) vaccine works in pregnant women and their b...

10 locations(Idaho Falls, Idaho Falls, Idaho Falls)
6,000 participants
Pfizer
View Study Details
RecruitingNCT01042379

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learn...

10 locations(Birmingham, Scottsdale, Tucson)
5,000 participants
QuantumLeap Healthcare Collaborative
View Study Details
RecruitingNCT05543616

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy ch...

10 locations(Birmingham, Birmingham, Phoenix)
4,292 participants
BioNTech SE
View Study Details
RecruitingNCT06935370

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with c...

10 locations(Mobile, Montgomery, Beverly Hills)
4,200 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT02693535

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or ...

10 locations(Birmingham, Phoenix, Auburn)
4,200 participants
American Society of Clinical Oncology
View Study Details
RecruitingNCT04636814

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population....

10 locations(Andalusia, Foley, Guntersville)
3,980 participants
Chiesi Farmaceutici S.p.A.
View Study Details
RecruitingNCT03486873

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this ex...

10 locations(Tucson, Bakersfield, Fresno)
3,500 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT05026866

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approximately 800 additional participants will be enrolled...

10 locations(Birmingham, Homewood, Huntsville)
2,996 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05624450

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression t...

10 locations(Mobile, Phoenix, Phoenix)
2,870 participants
AstraZeneca
View Study Details
RecruitingNCT05443737

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young cancer survivors' engagement in goal-concordant oncofertility care, concurrently with obse...

4 locations(Duarte, El Centro, La Jolla)
2,800 participants
University of California, San Diego
View Study Details
RecruitingNCT06821061

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants i...

10 locations(Anaheim, Lake Forest, Riverside)
2,645 participants
BioNTech SE
View Study Details
RecruitingNCT06268873

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This study consists of a screening, a 4-week dapagliflo...

10 locations(Fairhope, Phoenix, Surprise)
2,500 participants
AstraZeneca
View Study Details
RecruitingNCT04606264

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

This REMAP Periop ERP domain study falls under the Periop Core Protocol, which compares the different recommended strategies for enhancing recovery through the use of various standard of care treatmen...

3 locations(Pittsburgh, Pittsburgh, Pittsburgh)
2,500 participants
Jennifer Holder-Murray
View Study Details
RecruitingNCT06679140

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progressio...

10 locations(Little Rock, Bakersfield, Inglewood)
2,330 participants
Pfizer
View Study Details
RecruitingNCT03488693

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers w...

10 locations(Fairbanks, Tucson, Tucson)
2,140 participants
Canadian Cancer Trials Group
View Study Details
RecruitingNCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....

10 locations(Birmingham, Scottsdale, Tempe)
2,100 participants
Pfizer
View Study Details
RecruitingNCT04453293

Immunization With BCG Vaccine to Prevent Tuberculosis Infection

The purpose of this research is to find out if a single dose of pre-travel vaccination with BCG can lessen tuberculosis (TB) infection by producing an immune response when given to adults traveling to...

7 locations(New Haven, Washington D.C., Decatur)
2,000 participants
Henry M. Jackson Foundation for the Advancement of Military Medicine
View Study Details
RecruitingNCT05878769

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week ...

10 locations(Birmingham, Dothan, Jasper)
2,000 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT05564390

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical tria...

10 locations(Birmingham, Phoenix, Tucson)
2,000 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT05763602

PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

The purpose of this study is to see whether applying povidone iodine (PVI) to the noses of patients undergoing lower extremity (leg, ankle, or foot) orthopedic fixation procedures of high-energy lower...

6 locations(Atlanta, Indianapolis, Iowa City)
2,000 participants
Loreen Herwaldt
View Study Details
RecruitingNCT06740630

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

The purpose of this study is to assess the consistency of immune response to three different lots of GSK's investigational varicella vaccine (VNS Vaccine), and to compare the safety and immune respons...

5 locations(Tampa, Bingham Farms, McAllen)
1,840 participants
GlaxoSmithKline
View Study Details
RecruitingNCT06736574

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in p...

10 locations(Alexander City, Birmingham, Tucson)
1,800 participants
Cytokinetics
View Study Details
RecruitingNCT06120491

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA by assessment of radiographic progression-free sur...

10 locations(Chandler, Gilbert, Phoenix)
1,800 participants
AstraZeneca
View Study Details
RecruitingNCT06632444

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

This study is open to adults who are at least 18 years old living with obesity and have: * a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic associated steatohepatitis (...

10 locations(Peoria, Scottsdale, Tucson)
1,800 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT06872892

The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

This study is open to adults with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations). The purpose of this study is to find ...

10 locations(Birmingham, Anchorage, Phoenix)
1,680 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT06141473

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of teriflunomide in male and female participants...

10 locations(Birmingham, Cullman, Homewood)
1,600 participants
Sanofi
View Study Details
RecruitingNCT05552222

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) ...

10 locations(Clovis, Duarte, Irvine)
1,590 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT06632457

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

This study is open to adults who are at least 18 years old and have: * A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or * A confirmed liver disease called metabolic-associated...

10 locations(Peoria, Peoria, Scottsdale)
1,590 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT05492578

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

This is an open-label, Phase 2/Phase 3, long-term extension study for treatment of participants of previous amlitelimab clinical trials in moderate to severe atopic dermatitis. The purpose of this st...

10 locations(Birmingham, Scottsdale, Anaheim)
1,551 participants
Sanofi
View Study Details
RecruitingNCT05304351

Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older

The purpose of this study is to assess the safety and immunogenicity of amezosvatein (CRV-101), an investigational vaccine compared to Shingrix® for the prevention of herpes zoster in adults aged 50 y...

10 locations(Tempe, Coral Gables, Oak Brook)
1,516 participants
Curevo Inc
View Study Details
RecruitingNCT06672016

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

The Sponsor is developing a progestin-only contraceptive transdermal system (patch). The main purpose of this study is to look at how safe the study patch is and how well it works in preventing pregn...

10 locations(Birmingham, Dothan, Mobile)
1,500 participants
Mylan Pharmaceuticals Inc
View Study Details
RecruitingNCT06012240

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the bod...

10 locations(Birmingham, Glendale, Phoenix)
1,500 participants
AbbVie
View Study Details
RecruitingNCT06925737

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-...

10 locations(Duarte, Irvine, La Jolla)
1,440 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT07001800

A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis

The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults....

10 locations(Birmingham, Huntsville, Beverly Hills)
1,410 participants
Kardigan, Inc.
View Study Details
RecruitingNCT05827081

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on in...

10 locations(Anchorage, Little Rock, Denver)
1,400 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT02445222

CAR-T Long Term Follow Up (LTFU) Study

Per Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is require...

10 locations(Phoenix, Duarte, Los Angeles)
1,400 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT06653153

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study ...

10 locations(Birmingham, Chandler, Mesa)
1,400 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06136624

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) ...

10 locations(Orange, Palo Alto, Riverside)
1,310 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06864143

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19 vaccine in adults ≥18 to \<65 years of age....

10 locations(Scottsdale, San Diego, Stockbridge)
1,300 participants
ModernaTX, Inc.
View Study Details
RecruitingNCT06838000

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

The purpose of this study is to evaluate the safety and immunogenicity of PCV21 versus 20vPCV ( 20-valent pneumococcal conjugate vaccine, Prevnar 20) for catch-up vaccination in infants (7 to 11 MoA-M...

10 locations(Paramount, Doral, Hialeah)
1,252 participants
Sanofi Pasteur, a Sanofi Company
View Study Details
RecruitingNCT07052903

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events * Evaluate the efficacy of nucresiran compare...

6 locations(Washington D.C., Brandon, Cumming)
1,250 participants
Alnylam Pharmaceuticals
View Study Details
RecruitingNCT06143956

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight ma...

10 locations(Chandler, Phoenix, Scottsdale)
1,217 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05827016

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly dia...

10 locations(Aurora, Jacksonville, Tampa)
1,216 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1...

10 locations(Dothan, Phoenix, Sun City)
1,200 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT05984277

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy...

10 locations(Prescott, Hot Springs, Springdale)
1,200 participants
AstraZeneca
View Study Details
RecruitingNCT06312176

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone rece...

10 locations(Chandler, Gilbert, Fullerton)
1,200 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06993792

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants who have obesity or overweight with or without type ...

10 locations(Tucson, San Ramon, Santa Ana)
1,200 participants
Eli Lilly and Company
View Study Details
RecruitingNCT02861573

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

The purpose of this study is to assess the safety and efficacy of pembrolizumab (MK-3475) combination therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will b...

10 locations(Los Angeles, Aurora, Cleveland)
1,200 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06129864

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HN...

10 locations(Birmingham, Phoenix, Prescott Valley)
1,145 participants
AstraZeneca
View Study Details
RecruitingNCT06445062

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with Standard(s) of Care (SOC...

10 locations(Chandler, Phoenix, Scottsdale)
1,130 participants
Revolution Medicines, Inc.
View Study Details
RecruitingNCT06047080

An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

The purpose of this study is to compare the efficacy and safety of glofitamab in combination with polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) vs Pola...

10 locations(Anchorage, Anaheim, Clovis)
1,130 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT06628908

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

10 locations(Anniston, Birmingham, Daphne)
1,100 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingNCT06025578

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis....

10 locations(Birmingham, Phoenix, Phoenix)
1,092 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT05125302

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Mig...

10 locations(Huntsville, Saraland, Phoenix)
1,059 participants
AbbVie
View Study Details
RecruitingNCT06717347

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment ...

10 locations(Tucson, Los Alamitos, Los Angeles)
1,046 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06052059

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisok...

10 locations(Dothan, Fairhope, Litchfield Park)
1,020 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06760637

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people wi...

10 locations(Birmingham, Birmingham, Birmingham)
1,020 participants
Pfizer
View Study Details
RecruitingNCT06119581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

The purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated ad...

10 locations(Huntsville, Gilbert, Phoenix)
1,016 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05862272

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatm...

10 locations(Mobile, Chandler, Mesa)
1,000 participants
Sumitomo Pharma Switzerland GmbH
View Study Details
RecruitingNCT06676319

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma. The purpose of this study is to assess the efficacy, safety, and tolerability...

10 locations(Saraland, Chandler, Sun City)
1,000 participants
Sanofi
View Study Details
RecruitingNCT06662786

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (f...

10 locations(Gilbert, Jonesboro, Bakersfield)
1,000 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT06561386

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squa...

10 locations(Tucson, Los Angeles, Sacramento)
1,000 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT07018700

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

In this clinical trial, participants with episodic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine d...

8 locations(Phoenix, Los Angeles, Decatur)
990 participants
Merz Therapeutics GmbH
View Study Details
RecruitingNCT06541704

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (...

10 locations(Phoenix, Phoenix, Phoenix)
975 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNCT06948422

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

The GZPL master protocol will support 2 independent studies, J2A-MC-GZL1 (GZL1) and J2A-MC-GZL2 (GZL2). The purpose of this study is to create a framework to evaluate the safety and efficacy of orforg...

10 locations(Phoenix, Covina, Northridge)
974 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06764485

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate Cancer....

10 locations(Birmingham, Gilbert, Anaheim)
960 participants
Celgene
View Study Details
RecruitingNCT06212999

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment wi...

10 locations(Phoenix, Scottsdale, Fort Smith)
960 participants
Incyte Corporation
View Study Details
RecruitingNCT04375033

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous (in the belly area) formulation of buprenorphine at a target dose of 300mg is superior in retaining Veterans in opioid tre...

10 locations(Tuscaloosa, Phoenix, Long Beach)
952 participants
VA Office of Research and Development
View Study Details
RecruitingNCT04895709

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab or docetaxel in participants with advanced solid...

10 locations(Clovis, Los Angeles, Newport Beach)
949 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT05020236

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple myeloma compared to a combination therapy inclu...

10 locations(Clovis, Clovis, Fresno)
944 participants
Pfizer
View Study Details
RecruitingNCT06455202

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating ...

10 locations(Cullman, Litchfield Park, Scottsdale)
915 participants
Celldex Therapeutics
View Study Details
RecruitingNCT06445023

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating ...

10 locations(Birmingham, Scottsdale, Fountain Valley)
915 participants
Celldex Therapeutics
View Study Details
RecruitingNCT06914895

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 week...

10 locations(Goleta, Santa Clarita, Aurora)
905 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05769777

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD). The purpose of this study is to characterize the long-term safety a...

10 locations(Birmingham, Litchfield Park, Phoenix)
901 participants
Sanofi
View Study Details
RecruitingNCT05764733

Bone, Exercise, Alendronate, and Caloric Restriction

The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and l...

2 locations(Aurora, Winston)
900 participants
Wake Forest University Health Sciences
View Study Details
RecruitingNCT02960022

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutam...

10 locations(Anchorage, Tucson, Los Angeles)
900 participants
Astellas Pharma Global Development, Inc.
View Study Details
RecruitingNCT06629779

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC who are ARSi or abirat...

10 locations(Chandler, Gilbert, Glendale)
900 participants
Pfizer
View Study Details
RecruitingNCT06141486

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to 36 months ...

10 locations(Homewood, Phoenix, Scottsdale)
900 participants
Sanofi
View Study Details
RecruitingNCT03564340

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

The main purpose of this study is to: * Learn about the safety of ubamatamab and to find out what dose of ubamatamab can be given alone or with cemiplimab to patients with ovarian cancer or cancer of...

10 locations(Birmingham, Boston, Boston)
890 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNCT06692738

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squam...

10 locations(Tucson, Springdale, Beverly Hills)
880 participants
AstraZeneca
View Study Details
RecruitingNCT06580314

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III o...

10 locations(Birmingham, Anchorage, Anchorage)
880 participants
NRG Oncology
View Study Details
RecruitingNCT06868264

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV....

10 locations(Birmingham, Dothan, Chandler)
880 participants
Atea Pharmaceuticals, Inc.
View Study Details
RecruitingNCT06627647

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

The purpose of ARTEMIDE-Lung03 is to evaluate the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with platinum-based doublet chemotherapy, as a first-line treatmen...

10 locations(Mobile, Chandler, Phoenix)
878 participants
AstraZeneca
View Study Details
RecruitingNCT05538663

Intravesical BCG vs GEMDOCE in NMIBC

The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will result in a non-inferior event-free survival...

10 locations(Birmingham, Fairbanks, Gilbert)
870 participants
ECOG-ACRIN Cancer Research Group
View Study Details
RecruitingNCT06356129

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

The purpose of this study is to compare the effectiveness and safety of golcadomide in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy vs p...

10 locations(Mobile, Anchorage, Phoenix)
850 participants
Celgene
View Study Details

Frequently Asked Questions

What clinical trials are available for Retinitis Pigmentosa?

There are currently 100 actively recruiting clinical trials for retinitis pigmentosa. These studies are testing new treatments, therapies, and interventions at research sites across 282 cities.

How do I join a Retinitis Pigmentosa clinical trial?

To join a retinitis pigmentosa clinical trial: 1) Browse the available studies above, 2) Click on a study that interests you, 3) Complete the eligibility form, and 4) A study coordinator will contact you.

Are clinical trials free for patients?

Yes, clinical trial participation is free. In most studies, the treatment, medical tests, and doctor visits related to the trial are provided at no cost. Some studies may also compensate for time and travel.

Can I leave a clinical trial if I change my mind?

Yes, participation in any clinical trial is completely voluntary. You can withdraw at any time, for any reason, without affecting your regular medical care.